ZA200800112B - Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl) [4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof - Google Patents

Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl) [4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof

Info

Publication number
ZA200800112B
ZA200800112B ZA200800112A ZA200800112A ZA200800112B ZA 200800112 B ZA200800112 B ZA 200800112B ZA 200800112 A ZA200800112 A ZA 200800112A ZA 200800112 A ZA200800112 A ZA 200800112A ZA 200800112 B ZA200800112 B ZA 200800112B
Authority
ZA
South Africa
Prior art keywords
phthalazin
micronised
pyridylmethyl
chlorophenyl
immediate
Prior art date
Application number
ZA200800112A
Other languages
English (en)
Inventor
Kai Juergens
Thomas Backensfeld
Torsten Wagner
Adrian Funke
Kai Thode
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of ZA200800112B publication Critical patent/ZA200800112B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200800112A 2005-06-07 2008-01-04 Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl) [4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof ZA200800112B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05090166A EP1731153A1 (en) 2005-06-07 2005-06-07 Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)¬4-(4-pyridylmethyl)phthalazin-1-yl| and salts thereof

Publications (1)

Publication Number Publication Date
ZA200800112B true ZA200800112B (en) 2010-06-30

Family

ID=34938467

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200800112A ZA200800112B (en) 2005-06-07 2008-01-04 Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl) [4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof

Country Status (21)

Country Link
EP (2) EP1731153A1 (es)
JP (1) JP2008542420A (es)
KR (1) KR20080031005A (es)
CN (1) CN101242840A (es)
AR (1) AR053889A1 (es)
AU (1) AU2006256852A1 (es)
BR (1) BRPI0613393A2 (es)
CA (1) CA2610975A1 (es)
CR (1) CR9563A (es)
DO (1) DOP2006000127A (es)
EC (1) ECSP078038A (es)
GT (1) GT200600242A (es)
IL (1) IL187905A0 (es)
MX (1) MX2007015494A (es)
NO (1) NO20080065L (es)
PE (1) PE20070319A1 (es)
RU (1) RU2007147951A (es)
TW (1) TW200716115A (es)
UY (1) UY29582A1 (es)
WO (1) WO2006131393A1 (es)
ZA (1) ZA200800112B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1958616A1 (en) * 2007-02-13 2008-08-20 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical formulations of 1-[4-chloroanilino]-4-[4-pyridylmethyl] phthalazine or salts thereof
WO2016020901A1 (en) 2014-08-07 2016-02-11 Acerta Pharma B.V. Methods of treating cancers, immune and autoimmune diseases, and inflammatory diseases based on btk occupancy and btk resynthesis rate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4950519A1 (es) * 1997-02-13 2000-09-01 Novartis Ag Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion

Also Published As

Publication number Publication date
DOP2006000127A (es) 2006-12-15
RU2007147951A (ru) 2009-07-20
PE20070319A1 (es) 2007-04-12
KR20080031005A (ko) 2008-04-07
JP2008542420A (ja) 2008-11-27
EP1731153A1 (en) 2006-12-13
WO2006131393A1 (en) 2006-12-14
ECSP078038A (es) 2008-01-23
BRPI0613393A2 (pt) 2011-01-11
NO20080065L (no) 2008-03-06
EP1888072A1 (en) 2008-02-20
AR053889A1 (es) 2007-05-23
CN101242840A (zh) 2008-08-13
CA2610975A1 (en) 2006-12-14
GT200600242A (es) 2007-02-09
AU2006256852A8 (en) 2006-12-14
UY29582A1 (es) 2007-01-31
IL187905A0 (en) 2008-03-20
MX2007015494A (es) 2008-02-22
TW200716115A (en) 2007-05-01
CR9563A (es) 2008-02-20
AU2006256852A1 (en) 2006-12-14

Similar Documents

Publication Publication Date Title
IL228017A0 (en) Quinazolinone derivatives donated at position 5 as anti-cancer agents
IL184735A0 (en) Pharmaceutical formulations and methods of use
IL206204A0 (en) Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and uses thereof
AP2655A (en) Capsule formulation of pirfenidone and pharmaceutically acceptable excipients
IL221770A (en) Edamantyl acetamide derivatives, the pharmaceutical composition containing them and its use in the preparation of a drug
IL199397A (en) Hetero-ring compounds, pharmaceuticals containing them, and their medicinal products
IL197442A (en) Therapeutic compositions containing glp-elp fusion proteins and their use in preparing a drug
PL1890681T3 (pl) Kompozycja granulowana na sucho zawierająca emtrycytabinę i tenofowir DF
IL188921A0 (en) Solid pharmaceutical composition comprising 1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine and a ph modifier
IL188583A0 (en) Pharmaceutical dosage form containing an active principle combination of nifedipine and/or nisoldipine and of an angiotensin ii antagonist
EP2015740A4 (en) NEW LOW-DOSED PHARMACEUTICAL COMPOSITIONS WITH NIMESULID, PREPARATION AND USE
IL182054A0 (en) Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors
IL197452A0 (en) New imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular cdc7
IL187906A0 (en) Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
IL187905A0 (en) Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl]and salts thereof
PL1655026T3 (pl) Zawierające diacereinę i meloksikam stałe preparaty farmaceutyczne
EP1906919A4 (en) MULTIPLE ACTIVE PHARMACEUTICAL PRINCIPLES COMBINED IN DISCRETE INHALATION PARTICLES AND THEIR FORMULATIONS
BRPI0608722A2 (pt) derivado de pirazolpirimidina ou sal medicinalmente aceitável do mesmo, composição farmacêutica, inibidor de mapkap-k2, e, agente terapêutico
ZA200804086B (en) Stable pharmaceutical formulations containing escitalo-pram and bupropion
HK1117058A (en) Solid pharmaceutical composition comprising 1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine and a ph modifier
GB0610207D0 (en) New forms of active pharmaceutical ingredient
TH87914B (th) สูตรผสมทางเภสัชกรรมที่โหลดยาสูง และปล่อยออกทันที่ของ นอน-ไมโครไนเซด (4-คลอโรเฟนิล)[4-(4-พิริดิลเมธิล)ฟแธเลซิน-1-อิล] และเกลือของสารเหล่านั้น
HK1098970A (en) Stable pharmaceutical formulations of benzimidazole compounds
HK1116040A (en) Drug-containing implants and methods of use thereof
AU2005902493A0 (en) Method and composition for use in preparation of a patient for surgery